Abstract
We previously conducted a randomized controlled study to examine persuasive messages recommending HPV vaccination to mothers with daughters in Japan. That study showed that the three types of intervention message used (statistical information only, a patient’s narrative in addition to statistical information, and a mother’s narrative in addition to statistical information) all significantly improved mothers’ intention to have their daughter(s) receive the HPV vaccine, in comparison with mothers who received no messaging. The present study is a follow-up survey to assess the long-term effect of the intervention. Four months after the initial study, in January 2018, participants in the previous study were contacted and queried about their current intention to have their daughter(s) receive the HPV vaccine. Statistical analysis was conducted using the paired t-test and analysis of variance. A total of 978 mothers participated in the current survey. Vaccination intention 4 months after intervention had decreased to a level that did not differ significantly from the level prior to intervention in all three intervention conditions. The amount of change in vaccination intention 4 months after intervention did not differ significantly among the three intervention groups (p = 0.871). A single exposure to messaging was insufficient to produce a persistent intervention effect.
Highlights
The human papillomavirus (HPV) vaccines have contributed to reduce the public health burden of cervical cancer [1,2,3]
The long-term effects of messages should be investigated because HPV vaccination expects multiple injections given over a series of weeks: In Japan, the second dose is given 1 month after and the third dose is given 6 months after the first dose
Our previous study showed that HPV vaccination intention increased significantly directly after intervention using study statistical messages only,vaccination a patient’sintention narrativeincreased in addition to statistical messages, Our previous showed that HPV
Summary
The human papillomavirus (HPV) vaccines have contributed to reduce the public health burden of cervical cancer [1,2,3]. Widespread uptake of the vaccine is necessary for this advance. Proactive recommendation of HPV vaccination was suspended by the Ministry of Health, Labour and Welfare in June 2013 in Japan after negative campaigns by mass media about severe adverse reactions allegedly caused by HPV vaccination [4]. The HPV vaccination rate among age-eligible girls has been stagnating, with only 0.3 percent of girls being vaccinated [5]. Individuals have fears concerning adverse reactions to HPV vaccination in
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.